| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $237.74 ▼ -1.06% | Yesterday | $241.36 ▲ +0.45% | Tomorrow's Ascendis Pharma A/S Ordinary Share (ASND) setup is anchored to $240.29 and targets $237.74 (-1.06%). The near-term read is downside; watch $247.50 / $233.08 because daily realized volatility is about 5.47%. |
Tomorrow's Ascendis Pharma A/S Ordinary Share (ASND) setup is anchored to $240.29 and targets $237.74 (-1.06%). The near-term read is downside; watch $247.50 / $233.08 because daily realized volatility is about 5.47%. | ||||
| Week | $232.36 ▼ -3.30% | Last Week | $243.62 ▲ +1.39% | The 7-day Ascendis Pharma A/S Ordinary Share model moves from $243.62 to $232.36 (-3.30%). It gives downside momentum context for this stock, so breaks around $247.50 / $233.08 matter more than a single tick. |
The 7-day Ascendis Pharma A/S Ordinary Share model moves from $243.62 to $232.36 (-3.30%). It gives downside momentum context for this stock, so breaks around $247.50 / $233.08 matter more than a single tick. | ||||
| Month | $223.40 ▼ -7.03% | Last Month | $247.38 ▲ +2.95% | The 1-month Ascendis Pharma A/S Ordinary Share target is $223.40 (-7.03%), compared with the live reference near $240.29. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Ascendis Pharma A/S Ordinary Share target is $223.40 (-7.03%), compared with the live reference near $240.29. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $209.97 ▼ -12.62% | Last Year | $253.02 ▲ +5.30% | The 1-year Ascendis Pharma A/S Ordinary Share scenario points to $209.97 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Ascendis Pharma A/S Ordinary Share scenario points to $209.97 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $178.50 ▼ -25.71% | 5 Years Ago | $266.24 ▲ +10.80% | The 5-year Ascendis Pharma A/S Ordinary Share view is $178.50 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Ascendis Pharma A/S Ordinary Share view is $178.50 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $240.29 | Mid |
| Daily Change | -2.07% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 62% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $240.29 | Daily Change | -2.07% |
| Market Cap | $14.89B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.